Helping to Inform Treatment Decisions
with Saizen^® easypod^®

Indication:
Pediatric Patients
Saizen^® [somatropin (rDNA origin) for injection] is indicated for the treatment of children with growth failure due to inadequate secretion of endogenous growth hormone.
Adult Patients
Saizen^® [somatropin (rDNA origin) for injection] is indicated for replacement of endogenous growth hormone in adults with adult or childhood onset growth hormone deficiency.

Important Safety Information: Saizen^® is contraindicated in patients with a known hypersensitivity to growth hormone, diabetic retinopathy, acute critical illness in the presence of active malignancy, and in patients with Prader-Willi syndrome who are severely obese or have severe respiratory impairment. Saizen^® should be used with caution in patients with insulin resistance, glucose intolerance, diabetes, hypothyroidism, intracranial hypertension and in women who are pregnant or nursing. Although infrequent, delivery site reactions may occur. Saizen^®, easypod^®, click.easy^®, cool.click^®2 and one.click^® are available by prescription only. Please refer to Full Prescribing Information. Refer to device instructions for use of easypod^®.

This Web site contains medical information intended for residents of the United States only.

This site was developed by EMD Serono, Inc. to educate patients and interested healthcare professionals about easypod^® and Saizen^® treatment for growth hormone deficiency.

This information is not intended to replace discussions with your healthcare professional. For additional information about Saizen^®, please read the
Saizen^® Full Prescribing Information and the easypod^®, click.easy^® and cool.click^®2 Instructions for Use and talk to your healthcare professional. You can also call Connections For Growth^® toll free at 800-582-7989, or visit www.saizenus.com.

Saizen^®, click.easy^®, cool.click^®2 and easypod^® are available by prescription only. Only your healthcare professional can prescribe Saizen^®, easypod^® and cool.click^®2.

Use and access of this site is subject to terms and conditions as set forth in our Legal Statement and Privacy Policy.